These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2096628)

  • 1. Stroma-free hemoglobin solutions prepared by crystallization and ultrafiltration methods; comparison of composition and coronary vasoconstrictor potency.
    Lang ME; Korecky B; Anderson PJ; Biro GP
    Adv Exp Med Biol; 1990; 277():225-36. PubMed ID: 2096628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine deaminase in stroma-free hemoglobin solution is not responsible for coronary vasoconstriction.
    Lawless K; Anderson PJ; Biro GP
    Adv Exp Med Biol; 1989; 248():365-70. PubMed ID: 2782159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of stroma-free hemoglobin solutions on isolated perfused rabbit hearts and isolated perfused rat kidneys.
    Vogel WM; Lieberthal W; Apstein CS; Levinsky N; Valeri CR
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):227-35. PubMed ID: 3140918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary vascular actions of stroma-free hemoglobin preparations.
    Biro GP; Taichman GC; Lada B; Keon WJ; Rosen AL; Sehgal LR
    Artif Organs; 1988 Feb; 12(1):40-50. PubMed ID: 3355384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary constrictor effect of stroma-free hemoglobin solutions.
    Vogel WM; Dennis RC; Cassidy G; Apstein CS; Valeri CR
    Am J Physiol; 1986 Aug; 251(2 Pt 2):H413-20. PubMed ID: 3740293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the mechanism of the vasoconstrictor activity of stroma-free hemoglobin in the isolated perfused rat kidney and rabbit heart.
    Lieberthal W; Vogel WM; Apstein CS; Valeri CR
    Prog Clin Biol Res; 1989; 319():407-20; discussion 421-2. PubMed ID: 2622922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced coronary vasoconstrictor activity of hemoglobin solutions purified by ATP-agarose affinity chromatography.
    Vogel WM; Hsia JC; Briggs LL; Er SS; Cassidy G; Apstein CS; Valeri CR
    Life Sci; 1987 Jul; 41(1):89-93. PubMed ID: 3600177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hemoglobin perfusion on contractile function of the isolated ventricular septa.
    Kim HW; Feola M; Rowley BA; Roberts LA
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):331-45. PubMed ID: 3179474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on blood substitutes based on hemoglobin and perfluorocarbon.
    Biro GP; Jing N; Anderson PJ
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1013-20. PubMed ID: 1391419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasoconstrictor activity of purified and modified human hemoglobin.
    Macdonald VW; Winslow RM; Marini MA; Klinker MT
    Biomater Artif Cells Artif Organs; 1990; 18(2):263-82. PubMed ID: 2369650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methemoglobin-induced decrease of vascular reactivity to human stroma-free hemoglobin in isolated perfused rabbit hearts.
    Macdonald VW
    Prog Clin Biol Res; 1989; 319():423-33; discussion 434. PubMed ID: 2622923
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronotropic effects of in vitro perfusion with albumin, stroma-free hemoglobin, and polyhemoglobin solutions.
    Walter SV; Chang TM
    Biomater Artif Cells Artif Organs; 1990; 18(2):283-98. PubMed ID: 2369651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of atenolol and pindolol on the phorbol ester-induced coronary vasoconstriction in the isolated perfused heart of the rat.
    Ruskoaho H
    Br J Pharmacol; 1988 Jun; 94(2):573-83. PubMed ID: 2840163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by plasma proteins of the isolated lamb heart perfused with stroma-free hemoglobin at 38 degrees.
    Suaudeau J; Fallon JT; Kunica E; Austen WG; Erdmann AJ
    Ann Surg; 1979 Mar; 189(3):322-33. PubMed ID: 371557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary vasoconstrictor and vasodilator actions of arachidonic acid in the isolated perfused heart of the rat.
    Belo SE; Talesnik J
    Br J Pharmacol; 1982 Feb; 75(2):269-86. PubMed ID: 6764740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality control material containing hemoglobin for blood gas and pH measurement: preparation of stroma-free hemoglobin solution.
    Sprokholt R; van Ooik S; van den Camp RA; Bouma BN; Zijlstra WG; Maas AH
    Scand J Clin Lab Invest Suppl; 1987; 188():69-82. PubMed ID: 3482482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential actions of platelet-activating factor (PAF) receptor antagonists on the vasodilator and vasoconstrictor effects of PAF in the rat perfused heart.
    Hu WM; Man RY
    Br J Pharmacol; 1991 Dec; 104(4):773-5. PubMed ID: 1667284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity.
    Resta TC; Walker BR; Eichinger MR; Doyle MP
    J Appl Physiol (1985); 2002 Oct; 93(4):1327-36. PubMed ID: 12235032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preparation of stroma-free hemoglobin by selective DEAE-cellulose absorption.
    Cheung LC; Storm CB; Gabriel BW; Anderson WA
    Anal Biochem; 1984 Mar; 137(2):481-4. PubMed ID: 6731830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.